Temporarily closed for submissions. Will reopen July 2018.

American Journal of Law & Medicine

The American Journal of Law & Medicine (AJLM) is the country’s leading health law journal. Its scope is broad, covering topics ranging from health law and policy, to the legal, ethical and economic aspects of medical practice, research and education. The journal publishes articles written by professors, attorneys and other professionals, as well as student notes and comments. AJLM is also a peer-reviewed journal, with leading experts in health law reviewing every manuscript selected for publication. It is published by the Boston University School of Law in conjunction with the American Society of Law, Medicine & Ethics.

Call for Papers

March 28th, 2018

The Crisis of Democracy in Healthcare: General Call for Papers

Democracy has consistently been considered the best form of government for allowing citizens’ voices to be heard. However, this is not always true in practice. Recent events in the United States have created climates where many voters were dissatisfied with not only the outcomes of elections, but with the policy choices that followed. This dissatisfaction can especially be seen with health policy. Many people feel as though their voices were not being heard at all and that their governments failed them. Many people also feel as if their elected officials have misguided agendas and that they should take matters into their own hands. This led our editorial board to the question: is there a crisis of democracy in 2018?

The next few volumes of the American Journal of Law and Medicine will have the theme of The Crisis of Democracy in Healthcare. This is a call for papers that examine topics of comparative health law, regulatory matters, election challenges, and public opinion’s impact on public health and health law. Papers that tackle other unique perspectives on the crisis of democracy will also be considered. This is an open call for papers from any academic perspective, including, but not limited to, law, public health, medicine, economics, bioethics, history and anthropology. Please submit a manuscript, a cover letter, an abstract, and a resume/CV.* Topics will be broadly considered and normal American Journal of Law and Medicine Submission Guidelines apply. Papers should be a minimum of thirty pages in length with at least 100 references.

 

The Crisis of Democracy in Healthcare: Symposium Call for Papers

The 2019 American Journal of Law and Medicine symposium will be titled, The Crisis of Democracy in Healthcare: Non-legislative Efforts to Change Health Law. Panels will discuss the crisis of democracy in healthcare in four specific areas: executive and administrative law, judicial action, public opinion research, and federalism. Again, this is an open call for papers from any academic perspective, including, but not limited to, law, public health, medicine, economics, bioethics, history and anthropology.

Accepted papers will be published in the Symposium Edition and presented at the symposium at Boston University. Please send a one page abstract, as well as complete contact information and a resume/CV, to ajlm@bu.edu by August 15, 2018. Selected authors will be notified by August 22, 2018. Full-length articles should be submitted by early January 2019 for inclusion in the symposium. Completed articles must be no longer than 7,000 words, include citations, and must touch on some aspect of the four categories given above and how it relates to the Crisis of Democracy in Healthcare. AJLM pays for reasonable travel expenses of invited authors.

 

IF YOU WISH TO BE CONSIDERED FOR BOTH THE SYMPOSIUM ISSUE AND GENERAL ISSUE, PLEASE INDICATE THIS IN YOUR SUBMISSION PACKAGE. PLEASE FOLLOW THE GUIDELINES FOR BOTH CALLS FOR PAPERS.

 

* – Note: Our latest issue, 44.4, has already been filled. We will start accepting submissions again in July 2018.

 

 

 

Call for Papers

July 16th, 2017

21st Century Cures Act: A Cure for the 21st Century?

In the most recent major, bipartisan-passed bill, Congress enacted substantial changes to the biotechnology industry. Prompted by public outcry over price and access to pharmaceuticals, as well as industry pressure to alleviate regulatory constraints, the 21st Century Cures Act purports to both tackle hindrances in the biotechnological space and drive drug and device innovation. The goal, it seems, is to reinvigorate the pharmaceutical/device industry, while promoting access to these products — but can this bill accomplish such goals? What lies ahead for consumers and the industry?

The American Journal of Law and Medicine (AJLM) will hold its annual symposium on Friday, January 26, 2018. Our symposium is an opportunity for interdisciplinary scholars/professionals to share and publish their knowledge on the given topic. This year’s topic is: 21st Century Cures Act: A Cure for the 21st Century? Accepted papers will be published in our summer 2018 Symposium Edition and presented at the symposium in Boston. This is an open call for papers from any academic perspective, including, but not limited to, law, public health, medicine, economics, bioethics, business, and history.

Please send a one-page abstract, as well as complete contact information and resume/CV, to ajlm@bu.edu by Monday, October 16, 2017. Selected authors for presentation and publication will be notified by Friday, October 27, 2017. Full-length articles should be submitted by January 19, 2018, for inclusion in the Symposium Edition. Completed articles must be no longer than 7,000 words, include citations, and must touch on some aspect of the 21st Century Cures Act. AJLM pays for reasonable travel expenses of invited authors.

Call For Papers

April 28th, 2015

Global Infectious Diseases: New Challenges and Solutions

Infectious diseases were once relegated to the dustbin of history, but today emerging and re- emerging infectious diseases threaten health and health care systems in every country. Issues include whether we are blundering into a post-antibiotic apocalypse; how to prevent the emergence of global infectious diseases; and how to ensure equitable access to appropriate prevention and therapies across all income groups.

Recent events, such as the measles outbreak in the United States, the Ebola epidemic in West Africa, and litigation over a compounding pharmacy’s liability in the spread of fungal meningitis, highlight the legal, medical, and bioethical challenges posed by infectious diseases. This symposium will focus on the interdisciplinary considerations and obstacles raised by these and similar developments. Panels will discuss challenges and constraints to developing new treatments for infectious diseases, the global challenge of addressing diseases that do not recognize national borders, responsibilities relating to vaccination, the development of “super bugs” due to excessive use of antibiotics, and the possibility of expanding tort liability to cover the spread of infectious diseases.

AJLM will hold its annual symposium on Saturday, January 30, 2016. Accepted papers will be published in the Symposium Edition and presented at the symposium in Boston. This is an open call for papers from any academic perspective, including, but not limited to, law, public health, medicine, economics, bioethics, history and anthropology.

Please send a one page abstract, as well as complete contact information, to ajlmsymposium@gmail.com by May 1, 2015. Selected authors will be notified by May 15, 2015. Full-length articles should be submitted by October 2015 for inclusion in the symposium. AJLM pays for reasonable travel expenses of invited authors.